Advertisement


Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

David A. Hyman, MD, JD, on Inclusive Shared Savings

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement



Dec
09
Today In Oncology
Elacestrant May Improve Outcomes for Postmenopausal Patients With Progressive ER-Positive HER2-Negative Metastatic Breast Cancer (1)
PALLAS Trial Addition of Adjuvant Palbociclib to Endocrine Therapy in Early HR-Positive, HER2-Negative Breast Cancer
Single-Cell Spatial Analysis May Help to Predict Response to Neoadjuvant Atezolizumab in Patients With Triple-Negative Breast Cancer
Telemedicine Use Among U.S. Patients With Newly Diagnosed Cancer Impact of Socioeconomic Status
COVID-19 Infection After SARS–CoV-2 Messenger RNA Vaccination in Patients With Cancer
View More 
Advertisement
© 2021 HSP News Service, L.L.C.
Designed by Harborside